Skip to main content
. 2012 Dec 28;18(48):7242–7250. doi: 10.3748/wjg.v18.i48.7242

Table 3.

Results of survival analyses related to α-fetoprotein response

Author Year Overall survival Progression-free survival
HR 95%CI P value HR 95%CI P value
Chen et al[21] 2005 0.242 0.10-0.61 0.003 - - -
Chan et al[20] 2009 0.412 0.27-0.63 0.0001 - - -
Riaz et al[27] 2009 0.3712 0.13-1.011 0.0002 - - -
Vora et al[29] 2009 0.952 0.73-1.231 0.88 0.482 0.15-1.451 0.09
Shao et al[28] 2010 0.362 0.15-0.83 0.017 0.312 0.14-0.67 0.003
Kim et al[23] 2011 0.432 0.29-0.65 0.001 0.482 0.33-0.70 0.001
Yau et al[30] 2011 0.32 0.09-1.02 0.05 0.312 0.13-0.76 0.01
Kao et al[22] 2012 0.1812 0.02-1.67 0.023 - - -
Lee et al[24] 2012/H 0.432 0.23-0.81 0.009 0.672 0.35-1.27 0.22
Lee et al[24] 2012/C 0.332 0.15-0.75 0.008 0.972 0.42-2.25 0.97
Memon et al[25] 2012 0.142 0.02-0.83 0.03 - - -
Personeni et al[26] 2012 0.522 0.31-0.85 0.009 - - -
1

Calculated result from data presented in article;

2

Multivariate result; -: Not performed; 2012/H: Hepatic arterial infusional chemotherapy study; 2012/C: Concurrent chemoradiation therapy study; HR: Hazard ratio; AFP: α-fetoprotein.